Comparing China and US Drug Patent Linkage Regulations

by Grace Wang
Aug 20, 2021

China Rolls Out Measures for Resolving Drug Patent Disputes

China's two government agencies—National Medical Products Administration (NMPA) and China National Intellectual Property Administration (CNIPA)—recently issued the Measures for Implementing the Early Resolution Mechanism for Drug Patent Disputes (Trial) (hereinafter referred to as the Measures) with immediate effect.1

Grace Wang
ChemLinked Regulatory Analyst
Copyright: unless otherwise stated all contents of this website are ©2021 - REACH24H Consulting Group - All Rights Reserved - For permission to use any content on this site, please contact